Literature DB >> 12433878

Nitric oxide and myocardial function in heart failure: friend or foe?

J M Cotton1, M T Kearney, A M Shah.   

Abstract

There is good evidence that nitric oxide has important autocrine/paracrine effects in the myocardium, serving to optimise and fine tune cardiac function

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12433878      PMCID： PMC1767463          DOI： 10.1136/heart.88.6.564

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  36 in total

Review 1.  Paracrine and autocrine effects of nitric oxide on myocardial function.

Authors:  A M Shah; P A MacCarthy
Journal:  Pharmacol Ther       Date:  2000-04       Impact factor: 12.310

2.  Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes.

Authors:  M G Petroff; S H Kim; S Pepe; C Dessy; E Marbán; J L Balligand; S J Sollott
Journal:  Nat Cell Biol       Date:  2001-10       Impact factor: 28.824

Review 3.  Cellular and molecular mechanisms of endothelial cell dysfunction.

Authors:  D G Harrison
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

4.  Endogenous nitric oxide and myocardial adaptation to ischemia.

Authors:  G Heusch; H Post; M C Michel; M Kelm; R Schulz
Journal:  Circ Res       Date:  2000-07-21       Impact factor: 17.367

5.  Effects of nitric oxide synthase inhibition on Basal function and the force-frequency relationship in the normal and failing human heart in vivo.

Authors:  J M Cotton; M T Kearney; P A MacCarthy; R M Grocott-Mason; D R McClean; C Heymes; P J Richardson; A M Shah
Journal:  Circulation       Date:  2001-11-06       Impact factor: 29.690

6.  Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes.

Authors:  Joanne Layland; Jian-Mei Li; Ajay M Shah
Journal:  J Physiol       Date:  2002-04-15       Impact factor: 5.182

7.  No involvement of nitric oxide in the limitation of beta-adrenergic inotropic responsiveness during ischemia.

Authors:  H Post; R Schulz; P Gres; G Heusch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-12       Impact factor: 4.733

8.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

9.  8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes.

Authors:  A M Shah; H A Spurgeon; S J Sollott; A Talo; E G Lakatta
Journal:  Circ Res       Date:  1994-05       Impact factor: 17.367

10.  Nitric oxide synthase activities in human myocardium.

Authors:  A J de Belder; M W Radomski; H J Why; P J Richardson; C A Bucknall; E Salas; J F Martin; S Moncada
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321
View more
  18 in total

1.  β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4.

Authors:  Thomas J LaRocca; Martina Schwarzkopf; Perry Altman; Shihong Zhang; Achla Gupta; Ivone Gomes; Zikiar Alvin; Hunter C Champion; Georges Haddad; Roger J Hajjar; Lakshmi A Devi; Alison D Schecter; Sima T Tarzami
Journal:  J Cardiovasc Pharmacol       Date:  2010-11       Impact factor: 3.105

2.  The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic rings.

Authors:  Carmen Gonzalez; Hector Rosas-Hernandez; Brenda Jurado-Manzano; Manuel Alejandro Ramirez-Lee; Samuel Salazar-Garcia; Pedro Pablo Martinez-Cuevas; Aída Jimena Velarde-Salcedo; Humberto Morales-Loredo; Ricardo Espinosa-Tanguma; Syed F Ali; Rafael Rubio
Journal:  Acta Pharmacol Sin       Date:  2015-04-20       Impact factor: 6.150

Review 3.  The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure.

Authors:  Alexandros Briasoulis; Emmanuel Androulakis; Theodoros Christophides; Dimitris Tousoulis
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

4.  Influence of exercise on oxidative stress in patients with heart failure.

Authors:  Sabrina Weiss Sties; Leonardo Vidal Andreato; Tales de Carvalho; Ana Inês Gonzáles; Vitor Giatte Angarten; Anderson Zampier Ulbrich; Lourenço Sampaio de Mara; Almir Schmitt Netto; Edson Luiz da Silva; Alexandro Andrade
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

Review 5.  Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies.

Authors:  Dimitris Tousoulis; Nikolaos Papageorgiou; Alexandros Briasoulis; Emmanouel Androulakis; Marietta Charakida; Eleftherios Tsiamis; Christodoulos Stefanadis
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

6.  Role of proinflammatory cytokines and redox homeostasis in exercise-induced delayed progression of hypertension in spontaneously hypertensive rats.

Authors:  Deepmala Agarwal; Masudul Haque; Srinivas Sriramula; Nithya Mariappan; Romain Pariaut; Joseph Francis
Journal:  Hypertension       Date:  2009-10-19       Impact factor: 10.190

7.  The cardio-protective signaling and mechanisms of adiponectin.

Authors:  Gayani Nanayakkara; Thiruchelvan Kariharan; Lili Wang; Juming Zhong; Rajesh Amin
Journal:  Am J Cardiovasc Dis       Date:  2012-10-20

Review 8.  Molecular events in the cardiomyopathy of sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Markus S Huber-Lang; J Vidya Sarma; Peter A Ward
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

9.  Nitric oxide down-regulates voltage-gated Na+ channel in cardiomyocytes possibly through S-nitrosylation-mediated signaling.

Authors:  Pu Wang; Mengyan Wei; Xiufang Zhu; Yangong Liu; Kenshi Yoshimura; Mingqi Zheng; Gang Liu; Shinichiro Kume; Masaki Morishima; Tatsuki Kurokawa; Katsushige Ono
Journal:  Sci Rep       Date:  2021-05-28       Impact factor: 4.379

10.  Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production.

Authors:  Adrian T Gonon; Christian Jung; Abram Katz; Håkan Westerblad; Alexey Shemyakin; Per-Ove Sjöquist; Jon O Lundberg; John Pernow
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.